Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 431 publications

Pharmacologic management of ET: established therapies and emerging agents.

Pharmacologic management of ET: established therapies and emerging agents.

Journal: Expert opinion on pharmacotherapy
Published: October 27, 2025

Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers.

Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers.

Journal: Biomedicines
Published: July 19, 2025

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.

Journal: The Lancet. Haematology
Published: June 11, 2025

Leukocytoclastic Vasculitis in JAK2-Positive Essential Thrombocythemia: A Case of Cytokine-Driven Urticarial Rash Responsive to Ruxolitinib.

Leukocytoclastic Vasculitis in JAK2-Positive Essential Thrombocythemia: A Case of Cytokine-Driven Urticarial Rash Responsive to Ruxolitinib.

Journal: European journal of case reports in internal medicine
Published: June 10, 2025

Ruxolitinib and Hydroxycarbamide Are the Most Efficient Drugs to Reduce Aquagenic Pruritus Intensity in a Real-Word Cohort of Patients With Myeloproliferative Neoplasms.

Ruxolitinib and Hydroxycarbamide Are the Most Efficient Drugs to Reduce Aquagenic Pruritus Intensity in a Real-Word Cohort of Patients With Myeloproliferative Neoplasms.

Journal: EJHaem
Published: May 07, 2025

Cytoreductive treatment differentially affects platelet size and cytoskeletal megakaryocyte organization during thrombopoiesis in myeloproliferative neoplasms.

Cytoreductive treatment differentially affects platelet size and cytoskeletal megakaryocyte organization during thrombopoiesis in myeloproliferative neoplasms.

Journal: Experimental hematology
Published: April 28, 2025

An Unusual Case of Essential Thrombocythemia and Acute Kidney Injury: Case Report and Literature Review.

An Unusual Case of Essential Thrombocythemia and Acute Kidney Injury: Case Report and Literature Review.

Journal: Diseases (Basel, Switzerland)
Published: April 05, 2025

Advances in the diagnosis and treatment of thrombocytosis in children

Advances in the diagnosis and treatment of thrombocytosis in children

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: February 18, 2025

Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 17, 2025

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis.

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis.

Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 17, 2025

Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021.

Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021.

Journal: Therapeutic advances in hematology
Published: February 13, 2025

Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents.

Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents.

Journal: Drug delivery
Published: February 11, 2025
Showing 1-12 of 431

Last Updated: 01/07/2026